Cardlytics, Inc.

Informe acción NasdaqGM:CDLX

Capitalización de mercado: US$259.7m

Cardlytics Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Cardlytics han disminuido a una tasa media anual de -38.6%, mientras que en la industria Media los beneficios crecieron en un 5.7% anualmente. Los ingresos han ido creciendo a una tasa media de 10.9% al año.

Información clave

-38.6%

Tasa de crecimiento de los beneficios

-32.6%

Tasa de crecimiento del BPA

Crecimiento de la industria Media 13.2%
Tasa de crecimiento de los ingresos10.9%
Rentabilidad financiera-393.9%
Margen neto-93.6%
Última actualización de beneficios30 Sep 2024

Actualizaciones de resultados anteriores recientes

Recent updates

After Leaping 27% Cardlytics, Inc. (NASDAQ:CDLX) Shares Are Not Flying Under The Radar

Nov 05
After Leaping 27% Cardlytics, Inc. (NASDAQ:CDLX) Shares Are Not Flying Under The Radar

Is Cardlytics (NASDAQ:CDLX) Using Too Much Debt?

Oct 15
Is Cardlytics (NASDAQ:CDLX) Using Too Much Debt?

Cardlytics: Execution Risks Are Elevated, But Reasons For Optimism Remain (Maintain Hold Rating)

Sep 17

Cardlytics, Inc.'s (NASDAQ:CDLX) 63% Share Price Plunge Could Signal Some Risk

Aug 09
Cardlytics, Inc.'s (NASDAQ:CDLX) 63% Share Price Plunge Could Signal Some Risk

Cardlytics: Has Multiple Potential Growth Levers, But Persistent Risks Remain

Jul 02

Cardlytics, Inc.'s (NASDAQ:CDLX) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors

May 31
Cardlytics, Inc.'s (NASDAQ:CDLX) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors

The Power Of Cardlytics' Data Partnerships Including Bank of America

Apr 17

Cardlytics, Inc.'s (NASDAQ:CDLX) 81% Jump Shows Its Popularity With Investors

Apr 10
Cardlytics, Inc.'s (NASDAQ:CDLX) 81% Jump Shows Its Popularity With Investors

Cardlytics: Good Prospects But Macro Uncertain

Feb 16

Cardlytics, Inc.'s (NASDAQ:CDLX) 29% Share Price Plunge Could Signal Some Risk

Jan 18
Cardlytics, Inc.'s (NASDAQ:CDLX) 29% Share Price Plunge Could Signal Some Risk

Would Cardlytics (NASDAQ:CDLX) Be Better Off With Less Debt?

Jan 04
Would Cardlytics (NASDAQ:CDLX) Be Better Off With Less Debt?

We Think Cardlytics (NASDAQ:CDLX) Has A Fair Chunk Of Debt

Oct 05
We Think Cardlytics (NASDAQ:CDLX) Has A Fair Chunk Of Debt

Does Cardlytics (NASDAQ:CDLX) Have A Healthy Balance Sheet?

Jun 18
Does Cardlytics (NASDAQ:CDLX) Have A Healthy Balance Sheet?

Cardlytics, Inc. (NASDAQ:CDLX) Stock Rockets 105% But Many Are Still Ignoring The Company

Apr 17
Cardlytics, Inc. (NASDAQ:CDLX) Stock Rockets 105% But Many Are Still Ignoring The Company

Is Cardlytics, Inc. (NASDAQ:CDLX) Trading At A 38% Discount?

Mar 03
Is Cardlytics, Inc. (NASDAQ:CDLX) Trading At A 38% Discount?

Is Cardlytics (NASDAQ:CDLX) A Risky Investment?

Jan 10
Is Cardlytics (NASDAQ:CDLX) A Risky Investment?

Is Cardlytics (NASDAQ:CDLX) Using Debt In A Risky Way?

Oct 12
Is Cardlytics (NASDAQ:CDLX) Using Debt In A Risky Way?

Cardlytics: 6 Bear Cases To Consider

Oct 10

Desglose de ingresos y gastos

Cómo gana y gasta dinero Cardlytics. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

NasdaqGM:CDLX Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Sep 24293-27511252
30 Jun 24305-15311751
31 Mar 24312-17311853
31 Dec 23309-13511651
30 Sep 23303-41212653
30 Jun 23296-38212953
31 Mar 23295-48514152
31 Dec 22299-46515253
30 Sep 22306-9915050
30 Jun 22298-15015449
31 Mar 22282-7114544
31 Dec 21267-12913238
30 Sep 21244-12412031
30 Jun 21225-9410725
31 Mar 21195-679520
31 Dec 20187-559117
30 Sep 20189-458815
30 Jun 20199-388814
31 Mar 20220-248513
31 Dec 19210-178112
30 Sep 19189-328413
30 Jun 19167-337814
31 Mar 19154-397816
31 Dec 18151-537616
30 Sep 18142-466515
30 Jun 18139-416114
31 Mar 18136-335513
31 Dec 17130-255212
30 Sep 17128-285212
30 Jun 17127-515012
31 Mar 17120-775112
31 Dec 16113-775213
31 Dec 1578-425112

Ingresos de calidad: CDLX actualmente no es rentable.

Margen de beneficios creciente: CDLX actualmente no es rentable.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: CDLX no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 38.6% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de CDLX en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: CDLX no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Media (14%).


Rentabilidad financiera

Alta ROE: CDLX tiene una rentabilidad financiera negativa (-393.92%), ya que actualmente no es rentable.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado